ArticleDiabetology international2025

Immune checkpoint inhibitor-related type 1 diabetes mellitus with closely monitored dynamics of glutamic acid decarboxylase antibody levels before and after disease onset.

Taka-Aki Sakaue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.